
Sign up to save your podcasts
Or


Precision medicine will be available to everyone because of Tissue Chips. Hear the fascinating story of the most important technology you have never heard of before. In this episode of the Amazing Things Podcast, brought to you by United For Medical Research, we take you inside the Tissue Chip program - an NCATS collaboration with the Defense Advanced Research Projects Agency and FDA to support the development of bioengineered devices to improve the process of predicting whether drugs will be safe or toxic in humans.
The Ebola virus is a terrifying, rapidly fatal and until just recently untreatable disease with a mortality rate between 25% and 90%. In this episode of the Amazing Things Podcast, we take you inside the scientific discovery and the public-private partnership that turned the tide on Ebola and helped prepare America for the novel coronavirus. Featuring Dr. Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases and Neil Stahl, Ph.D. of Regeneron Pharmaceuticals, Inc.
The importance of strong, sustainable annual funding for the National Institutes of Health (NIH) is known to states with major biomedical R&D hubs like California, Massachusetts, North Carolina and Texas. In these states there is a clear link between the NIH-funded research that occurs there and the state’s economy and job creation. But what about states where such a link might be less apparent? What is the impact in states that tend to be more rural than urban and that aren’t among the top recipients of NIH research funding?
A discussion with National Institutes of Health director Dr. Francis Collins covering the new All of Us Research program, NIH’s work to combat the opioid epidemic, and advances like gene editing and cancer immunotherapy that are changing how we treat disease.
From the publisher's feed